1. Home
  2. SSL vs ALKS Comparison

SSL vs ALKS Comparison

Compare SSL & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sasol Ltd.

SSL

Sasol Ltd.

HOLD

Current Price

$12.16

Market Cap

5.6B

Sector

Energy

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$34.84

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSL
ALKS
Founded
1950
1987
Country
South Africa
Ireland
Employees
27411
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
4.5B
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
SSL
ALKS
Price
$12.16
$34.84
Analyst Decision
Sell
Buy
Analyst Count
1
14
Target Price
N/A
$43.29
AVG Volume (30 Days)
2.9M
2.4M
Earning Date
04-17-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.43
Revenue
N/A
$1,475,899,000.00
Revenue This Year
N/A
$24.26
Revenue Next Year
$4.48
$4.63
P/E Ratio
$13.51
$24.73
Revenue Growth
N/A
N/A
52 Week Low
$2.78
$25.17
52 Week High
$13.39
$36.32

Technical Indicators

Market Signals
Indicator
SSL
ALKS
Relative Strength Index (RSI) 62.95 70.03
Support Level $6.09 $27.89
Resistance Level N/A $34.84
Average True Range (ATR) 0.48 1.27
MACD -0.04 0.88
Stochastic Oscillator 47.47 81.28

Price Performance

Historical Comparison
SSL
ALKS

About SSL Sasol Ltd.

Sasol Ltd operates as a vertically integrated chemicals and energy company through its two main businesses: the Southern Africa Energy & Chemicals business and the International Chemical business. It generates maximum revenue from the Southern Africa Energy & Chemicals business, which operates integrated value chains with feedstock sourced from the Mining and Gas operating segments. Geographically, the company generates the majority of its revenue from South Africa.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: